Gan Jin, Yu Xiong, Duan Xin-Xing
General Surgery Center, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang No. 1 People's Hospital, Jiujiang 332000, Jiangxi Province, China.
World J Gastrointest Surg. 2025 Jul 27;17(7):103938. doi: 10.4240/wjgs.v17.i7.103938.
This study explores the 3-year survival outcomes and associated influencing factors in patients with primary gastric cancer treated laparoscopic surgery, providing meaningful guidance for clinical management.
To evaluate and analyze the 3-year survival outcomes and associated risk factors in patients with primary gastric cancer who underwent laparoscopic surgery.
A total of 100 patients with primary gastric cancer who underwent laparoscopic surgery at our hospital between January 2019 and December 2021 were enrolled. These patients were monitored for 3 years, and their survival statuses were recorded. Patients were categorized into survival and non-survival groups based on their outcomes. Data on sex, age, American Society of Anesthesiologists classification, tumor size, depth of invasion, postoperative adjuvant radio-chemotherapy, postoperative carcinoembryonic antigen (CEA) levels, and other clinical parameters were collected and contrasted across groups to identify factors impacting 3-year survival.
After a 3-year follow-up, the survival rate was 73.00% (73 of 100 patients). No significant differences were observed in sex, tumor location, alcohol consumption, smoking status, tumor differentiation, histological type, intraoperative blood loss, or surgical outcomes between patients with varying prognoses ( > 0.05). However, notable disparities were found in age, American Society of Anesthesiologists classification, tumor-node-metastasis (TNM) stage, tumor size, depth of invasion, lymph node metastasis, lymph node dissection, postoperative adjuvant radio-chemotherapy, postoperative CEA levels, surgical duration, extent of gastric resection, and postoperative complications ( < 0.05). Multivariate logistic regression analysis identified age, TNM stage, tumor size, depth of invasion, lymph node metastasis, lymph node dissection, postoperative adjuvant radio-chemotherapy, postoperative CEA levels, surgical duration, extent of gastric resection, and postoperative complications as independent predictors of 3-year survival in patients with primary gastric cancer following laparoscopic surgery ( < 0.05).
The 3-year survival outcome for patients undergoing laparoscopic surgery for primary gastric cancer was 73.00%. Key determinants of survival included age, TNM stage, tumor size, depth of invasion, and lymph node metastasis. This analysis of 3-year survival and its influencing factors offers novel perspectives for optimizing clinical interventions in patients with primary gastric cancer treated laparoscopic surgery.
本研究探讨接受腹腔镜手术治疗的原发性胃癌患者的3年生存结局及相关影响因素,为临床管理提供有意义的指导。
评估和分析接受腹腔镜手术的原发性胃癌患者的3年生存结局及相关危险因素。
选取2019年1月至2021年12月期间在我院接受腹腔镜手术的100例原发性胃癌患者。对这些患者进行3年的监测,并记录其生存状态。根据结局将患者分为生存组和非生存组。收集患者的性别、年龄、美国麻醉医师协会分级、肿瘤大小、浸润深度、术后辅助放化疗、术后癌胚抗原(CEA)水平及其他临床参数的数据,并在组间进行对比,以确定影响3年生存的因素。
经过3年的随访,生存率为73.00%(100例患者中的73例)。不同预后患者在性别、肿瘤位置、饮酒、吸烟状况、肿瘤分化、组织学类型、术中出血量或手术结局方面未观察到显著差异(>0.05)。然而,在年龄、美国麻醉医师协会分级、肿瘤-淋巴结-转移(TNM)分期、肿瘤大小、浸润深度、淋巴结转移、淋巴结清扫、术后辅助放化疗、术后CEA水平、手术时长、胃切除范围及术后并发症方面发现了显著差异(<0.05)。多因素logistic回归分析确定年龄、TNM分期、肿瘤大小、浸润深度、淋巴结转移、淋巴结清扫、术后辅助放化疗、术后CEA水平、手术时长、胃切除范围及术后并发症是腹腔镜手术后原发性胃癌患者3年生存的独立预测因素(<0.05)。
接受腹腔镜手术治疗的原发性胃癌患者的3年生存结局为73.00%。生存的关键决定因素包括年龄、TNM分期、肿瘤大小、浸润深度和淋巴结转移。对3年生存及其影响因素的分析为优化接受腹腔镜手术治疗的原发性胃癌患者的临床干预提供了新的视角。